Janssen-Cilag International NV announced today that the Committee for Human Medicinal Products (CHMP) in the European Union, has granted a positive opinion recommending approval of INVEGA? (paliperidone prolonged release tablets). INVEGA? is a new, once-daily, prolonged release oral medication, for the treatment of schizophrenia. [click link for full article]
From: www.medicalnewstoday.com
paliperidone) Receives Positive Opinion From European Committee For Human Medicinal Products For Treatment Of ...
Posted by Ruslan Abuzant at 1:55 AM
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment